Cargando…
Antitumor activity of a 5T4 targeting antibody drug conjugate with a novel payload derived from MMAF via C‐Lock linker
Antibody‐drug conjugates (ADCs) belong to a promising class of biopharmaceuticals in which target‐killing of tumor cells was achieved by marrying the potency of the cytotoxic payload with the tumor specificity of the antibody. Here we developed a novel ADC (ZV0508) that targets 5T4 oncofetal antigen...
Autores principales: | Shi, Baoying, Wu, Min, Li, Zhaohui, Xie, Zhangming, Wei, Xiaoyue, Fan, Jiansheng, Xu, Yingchun, Ding, Ding, Akash, Sajid Hamid, Chen, Shuqing, Cao, Sheldon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488119/ https://www.ncbi.nlm.nih.gov/pubmed/30843650 http://dx.doi.org/10.1002/cam4.2066 |
Ejemplares similares
-
Radiation Cleaved Drug-Conjugate Linkers Enable Local
Payload Release
por: Quintana, Jeremy M., et al.
Publicado: (2022) -
Antibody-Drug Conjugate Using Ionized Cys-Linker-MMAE as the Potent Payload Shows Optimal Therapeutic Safety
por: Wang, Yanming, et al.
Publicado: (2020) -
Linker Design Impacts Antibody-Drug Conjugate Pharmacokinetics and Efficacy via Modulating the Stability and Payload Release Efficiency
por: Su, Dian, et al.
Publicado: (2021) -
Antibody–drug conjugates: Recent advances in payloads
por: Wang, Zhijia, et al.
Publicado: (2023) -
Homozygous mutations in DZIP1 can induce asthenoteratospermia with severe MMAF
por: Lv, Mingrong, et al.
Publicado: (2020)